Lantus Sanofi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lantus sanofi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lantus Sanofi Today - Breaking & Trending Today
The Global Insulin Biosimilars Industry is on a trajectory of remarkable growth, with a projected worth of US$ 1,507.7 million in 2023 set to surge to over US$ 2,096.5 million by 2033. This surge is fueled by a robust adoption rate, with insulin biosimilars, alongside other insulin pharmaceutical products, anticipat. ....
The global insulin biosimilars market is worth US$ 1.47 Bn as of now and expected to reach US$ 5.88 Bn by the year 2032 at a stellar CAGR of 21.5% between 2022 and 2032.Biosimilar insulin has the capacity of reducing treatment costs of diabetes, increasing insulin treatment’s accessibility, and expanding number of v. ....
Real-world study confirms Basaglar is as safe and effective in type 2 diabetes as Lantus, both formulations of insulin glargine, but the former was cheaper and had better adherence. ....
(Representative image) MUMBAI: Call it the Covid effect. Popular health supplement Zincovit, which provides essential vitamins and minerals, catapulted to the top spot in the domestic pharma retail market for the first time ever in October by becoming the largest-selling brand. Interestingly, this would also be the first instance of a multivitamin supplement overtaking sales of drugs for lifestyle ailments such as diabetes, including Human Mixtard (Novo Nordisk), Glycomet-GP (USV) and Lantus (Sanofi), which dominate the retail market. A 30-year-old brand manufactured by the little known Apex Labs, Zincovit registered sales of Rs 50 crore during October, dethroning the largest-selling brand Human Mixtard (insulin) with sales of around Rs 47 crore. A multivitamin supplement topping retail sales assumes significance as it comes alongside an increase in month-on-month sales of Human Mixtard (see graphic), prompted by a strong need to prop one’s immunity amid a raging pandem ....
Synopsis A 30-year-old brand manufactured by the little-known Apex Labs, Zincovit registered sales of Rs 50 crore during October, dethroning the largest-selling brand Human Mixtard (insulin) with sales of around Rs 47 crore. ThinkStock Photos (This story originally appeared in on Dec 17, 2020)MUMBAI: Call it the Covid effect. Popular health supplement Zincovit, which provides essential vitamins and minerals, catapulted to the top spot in the domestic pharma retail market for the first time ever in October by becoming the largest-selling brand. Interestingly, this would also be the first instance of a multivitamin supplement overtaking sales of drugs for lifestyle ailments such as diabetes, including Human Mixtard (Novo Nordisk), Glycomet-GP (USV) and Lantus (Sanofi), which dominate the retail market. ....